Barclays: EU Q1 earnings show strongest growth in years

Barclays says Q1 blended EPS growth is tracking at 27% in the US and 7% in Europe, the strongest pace in more than four years in the US and more than three years in Europe. However, guidance in Europe has turned cautious, with about 75% of reported firms citing war-related impacts such as weaker demand, supply chain disruptions, or higher input costs. FY26 EPS revisions are turning positive in the US, led by AI, technology, energy, and semiconductors, while European revisions remain slightly negative.

Analysis

The key signal is not the headline EPS strength itself, but the divergence in revision breadth: the US is seeing earnings momentum concentrated in AI, semis, and energy while Europe is still fighting a negative revision cycle tied to war-linked cost pressure and weaker end-demand. That implies a second-order winner/loser map where US capex beneficiaries and domestic cyclicals can keep compounding, while European exporters and consumer brands face margin fragility even when they beat on the quarter. In other words, the market is rewarding forward revision intensity more than current-quarter beats.

The bigger medium-term implication is that earnings resilience is becoming self-reinforcing in the US through capex, productivity, and index-level multiple support, whereas Europe risks a valuation trap: cheap on trailing numbers, but with limited estimate upside unless the macro mix improves materially. If PMIs stabilize but remain US-led, capital will likely continue rotating toward US growth and away from European cyclicals, especially consumer discretionary names exposed to discretionary spending and input-cost pass-through limits. Financials are the subtle hedge here; they can benefit from still-firm activity data and a steeper revision profile without needing the same multiple expansion as tech.

The contrarian read is that consensus may be underestimating how much of the current strength is already priced into US mega-cap tech, while underappreciating the potential for a broadening into semis, industrial automation, and select financials if earnings revisions keep firming over the next 4-8 weeks. Conversely, Europe’s cautious guidance could be a delayed earnings recession signal rather than just war noise; if the conflict-driven cost shock persists into the next reporting window, margins in consumer and luxury-linked supply chains could see another leg down. That creates a setup where the near-term risk is not a broad market selloff, but a further dispersion trade across regions and sectors.

Key Decisions for Investors

• Go long SOXX / short a Europe proxy such as FEZ on a 1-2 month horizon: the revision gap favors US semis and AI-linked capex while European estimates remain negative; target 5-8% relative outperformance, stop if European revisions turn positive for two consecutive weeks.
• Buy calls on JPM or GS into the next 4-6 weeks versus shorting a European bank basket only if credit sensitivity rises: US financials can participate in resilient activity data and stable earnings breadth without the same geopolitical overhang.
• Fade European consumer discretionary/luxury via puts or a basket short (e.g., XLY equivalent Europe exposure if available) over the next earnings cycle: risk/reward is attractive because guidance is the weak point, not just the quarter; cover if management commentary turns constructive on China/US demand.
• Add to long INTC/AMAT-style US semiconductor and equipment exposure on pullbacks, with a 3-6 month view: the market is still underweight the second-order capex beneficiaries of AI spend; downside is a valuation reset if hyperscaler capex pauses.
• Use BCS as a relative value long only versus UK/EU banks with more consumer credit exposure, not as an outright macro bet: the bank’s own read suggests its franchise should be more insulated than the region, but any further Europe slowdown would cap upside.